A NEW APPROACH TO THE DEVELOPMENT OF ANTI-CANCER AGENTS-5-FU DERIVATIVES.OKADA T; NAKAYAMA M; MITSUI R et al.1974; HIROSHIMA J. MED. SCI.; JAP.; DA. 1974; VOL. 23; NO 2-3; PP. 51-76; BIBL. 19 REF.Article

Increased levels of thymidylate synthetase in cells exposed to 5-fluorouacilWASHTIEN, W. L.Molecular pharmacology. 1984, Vol 25, Num 1, pp 171-177, issn 0026-895XArticle

ANTITUMOR ACTIVITY OF BENZOYL AND BENZENESULFONYL DERIVATIVES OF 5-FLUOROURACILHOSHI A; IIGO M; NAKAMURA N et al.1974; GANN; JAP.; DA. 1974; VOL. 65; NO 5; PP. 463Article

USE OF FLUOROURACIL-URACIL COMBINATIONS TO STUDY GROWTH ACCOMPANIED BY INSUFFICIENT DEOXYRIBONUCLEIC ACID SYNTHESIS IN BACILLUS CEREUSDOOLITTLE CH; MANDEL HG; HAHN GA et al.1973; J. BACTERIOL.; U.S.A.; DA. 1973; VOL. 113; NO 3; PP. 1311-1319; BIBL. 26REF.Serial Issue

Maculopapular eruption resulting from systemic administration of 5-fluorouracilREED, W. P; MORRIS, D. M.Cutis (New York, NY). 1984, Vol 33, Num 4, pp 381-382, issn 0011-4162Article

REVERSED-PHASE LIQUID CHROMATOGRAPHY OF 5-FLUORO-URACIL NUCLEOSIDES AND NUCLEOTIDES IN THE PRESENCE OF QUATERNARY AMMONIUM IONSGELIJKENS CF; DE LEENHEER AP.1980; J. CHROMATOGR.; NLD; DA. 1980; VOL. 194; NO 3; PP. 305-314; BIBL. 39 REF.Article

THE ASSESSMENT OF RESPONSE OF MURINE TRANSPLANTABLE COLON TUMORS TO COMBINATION CHEMOTHERAPYCOWEN DM; SIEGERSTETTER J; JANIK AC et al.1982; JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY; ISSN 0171-5216; DEU; DA. 1982; VOL. 103; NO 2; PP. 119-126; BIBL. 9 REF.Article

5-FLUOROURACIL AND DERIVATIVES IN CANCER CHEMOTHERAPY. II. POSSIBLE IN VIVO FORMATION AND STABILIZATION OF 5-FLUORO-2-DEOXYURIDINE = LE FLUORO-5 URACILE ET SES DERIVES EN CHIMIOTHERAPIE ANTICANCEREUSE. II. FORMATION POSSIBLE IN VIVO ET STABILISATION DE FLUORO-5 DESOXY-2 URIDINEWINDHEUSER JJ; JATO J.1972; J. PHARM. SCI.; U.S.A.; DA. 1972; VOL. 61; NO 10; PP. 1669-1670; BIBL. 9REF.Serial Issue

CHEMOTHERAPEUTIC STUDY ON YOSHIDA SARCOMA ASCITES CELLS IMPLANTED INTO THE GLANDULAR STOMACH OF RATS: MONOTHERAPY WITH 5-FLUOROURACIL, METHYL-CCNU, MITOMYCIN C, ADRIAMYCIN, AND CYTOSINE ARABINOSIDE, AND COMBINATION THERAPY WITH RESPECTIVE TWO-DRUG COMBINATIONSEICHLER G; HABS M; SCHMAEHL D et al.1983; JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY; ISSN 0171-5216; DEU; DA. 1983; VOL. 105; NO 3; PP. 250-257; BIBL. 21 REF.Article

EFFET DIFFERENTIEL D'UNE IRRADIATION FRACTIONNEE ET DE L'ADMINISTRATION DE FLUORO-S URACILE SUR UNE TUMEUR MAMMAIRE CHEZ LA SOURIS BALB/C/CN^BMAISIN H; ANCKAERT MA; DECOSTER B et al.1983; COMPTES RENDUS DES SEANCES DE LA SOCIETE DE BIOLOGIE ET DE SES FILIALES; ISSN 0037-9026; FRA; DA. 1983; VOL. 177; NO 1; PP. 116-119; ABS. ENG; BIBL. 7 REF.Article

2.107.933 (B) (7134248). - 23SEPTEMBRE 1971. PROCEDE DE PREPARATION DU FLUORO-5 URACILEsdPatent

TWO MECHANISMS OF INTERFERON PRODUCTION BY LEUKOCYTES FROM IMMUNIZED ANIMALS = DEUX MECANISMES DE PRODUCTION D'INTERFERON PAR DES LEUCOCYTES D'ANIMAUX IMMUNISESTRUBINA LM; YAKOVENKO ZF; ZAKHARCHENKO EM et al.1975; ACTA VIROL.; TCHECOSL.; DA. 1975; VOL. 19; NO 2; PP. 116-120; BIBL. 10REF.Article

Tamoxifen and 5-fluorouracil in breast cancer: cytotoxic synergism in vitro = Le tamoxifène et le 5-fluorouracile dans le cancer du sein: synergie cytotoxique in vitroBENZ, C; CADMAN, E; GWIN, J et al.Cancer research (Baltimore). 1983, Vol 43, Num 11, pp 5298-5303, issn 0008-5472Article

Combined cytotoxic effect of low-dose 5-fluorouraciland hydroxyurea on 9L cells in vitro = Effets cytotoxiques combinés du 5-fluorouracile à faible dose et de l'hydroxyurée sur les cellules 9L in vitroKOBAYASHI, S; HOSHINO, T.Cancer research (Baltimore). 1983, Vol 43, Num 11, pp 5309-5313, issn 0008-5472Article

RAPID CATABOLISM OF 5-FLUOROURACIL IN FRESHLY ISOLATED RAT HEPATOCYTES AS ANALYZED BY HIGH PERFORMANCE LIQUID CHROMATOGRAPHYSOMMADOSSI JP; GEWIRTZ DA; DIASIO RB et al.1982; J. BIOL. CHEM.; ISSN 0021-9258; USA; DA. 1982; VOL. 257; NO 14; PP. 8171-8176; BIBL. 35 REF.Article

METABOLIC FATE OF 1-HEXYLCARBAMOYL-5-FLUOROURACIL AND 5-FLUOROURACIL IN MICE BEARING ASCITES SARCOMA 180IIGO M; KURETANI K; HOSHI A et al.1981; J. NATL. CANCER INST.; ISSN 0027-8874; USA; DA. 1981; VOL. 66; NO 2; PP. 345-349; BIBL. 13 REF.Article

5-Fluorouracil reduces biofilm formation in Escherichia coli K-12 through global regulator AriR as an antivirulence compoundATTILA, Can; UEDA, Akihiro; WOOD, Thomas K et al.Applied microbiology and biotechnology. 2009, Vol 82, Num 3, pp 525-533, issn 0175-7598, 9 p.Article

THE EFFECT OF POSTOPERATIVE RADIOTHERAPY ON THE FEASIBILITY OPTIMAL DOSE ADJUVANT CMF CHEMOTHERAPY IN STAGE II BREAST CARCINOMA = EFFETS DE LA RADIOTHERAPIE POST-OPERATOIRE SUR LA FAISABILITE DE LA CHIMIOTHERAPIE ADJUVANTE CMF A DOSES OPTIMALES DANS LE CANCER DU SEIN STADE IISULKES A; BRUFMAN G; RIZEL G et al.1983; INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY, BIOLOGY, PHYSICS; ISSN 0360-3016; USA; DA. 1983; VOL. 9; NO 1; PP. 17-21; ABS. ENG; BIBL. 18 REF.; GRAPHArticle

EPIDERMALE REAKTIONEN NACH HARNSTOFFEINWIRKUNG UND IHRE BEDEUTUNG FUER DIE EXTERNE THERAPIE = REACTIONS EPIDERMIQUES APRES ACTION DE L'UREE, LEUR IMPORTANCE POUR LE TRAITEMENT EXTERNEWOHLRAB W.1979; WISSENSCH. Z. MARTIN-LUTHER-UNIV. HALLE-WITTENBERG, MATH.-NATURWISSENSCH. REIHE; DDR; DA. 1979; VOL. 28; NO 2; PP. 15-19Article

SENSIBILITE ET RESISTANCE DES LEVURES PATHOGENES AUX 5-FLUOROPYRIMIDINES. II. ETUDE DES MECHANISMES DE RESISTANCE A LA 5-FLUOROCYTOSINE (5-FC) ET AU 5-FLUORO-URACILE (5-FU).MONTPLAISIR S; DROUHET E; MERCIER SOUCY L et al.1975; ANN. MICROBIOL.; FR.; DA. 1975; VOL. 126; NO 1; PP. 41-49; ABS. ANGL.; BIBL. 16 REF.Article

ETUDE DE L'EVOLUTION METABOLIQUE DU FLUORO-5 URACILE-¹⁴C-6 APRES ADMINISTRATION SOUS-CUTANEEOISHI T; SHIRAKI H; MINEURA K et al.1973; YAKUGAKU ZASSHI, J. PHARM. SOC. JAP.; JAP.; DA. 1973; VOL. 93; NO 6; PP. 749-755; ABS. ANGL.; BIBL. 5REF.Serial Issue

ETUDE COMPARATIVE DU METABOLISME DU FTORAFUR ET DE FLUORACILE DANS L'ORGANISMEGILLER SA; MEJREN DV; KHAGI KH B et al.1975; VOPR. ONKOL.; S.S.S.R.; DA. 1975; VOL. 21; NO 9; PP. 84-88; ABS. ANGL.; BIBL. 10 REF.Article

PROPRIETES ANTIINFLAMMATOIRES DE QUELQUES IMMUNODEPRESSEURSZAKS AS; RABOTNIKOV YU M; OVODENKO LA et al.1975; FARMAKOL. I TOKSIKOL.; S.S.S.R.; DA. 1975; VOL. 38; NO 5; PP. 587-589; ABS. ANGL.; BIBL. 1/2 P.Article

PHENOTYPIC REVERSION BY 5-FLUOROURACIL OF AMBER MUTATIONS IN BACTERIOPHAGE T4: CHARACTERIZATION OF RESCUED FUNCTIONSBOLUND C.1973; MOLEC. GEN. GENET.; GERM.; DA. 1973; VOL. 121; NO 3; PP. 247-258; BIBL. 1P.Serial Issue

INDIKATION UND RESULTATE DER ZYTOSTATISCHEN THERAPIE BEI MAGEN-DARM-TUMOREN = INDICATIONS ET RESULTATS DU TRAITEMENT CYTOSTATIQUE DES TUMEURS GASTRO-INTESTINALESBRUNNER KW.1973; SCHWEIZ. MED. WSCHR.; SCHWEIZ; DA. 1973; VOL. 103; NO 5; PP. 171-178; ABS. ANGL.; BIBL. 31 REF.Serial Issue